ISPAD Position Statement on Type 1 Diabetes in Schools

Pediatric Diabetes,Volume 19, Issue 7, Page 1338-1341, November 2018.
Source: Pediatric Diabetes - Category: Endocrinology Authors: Source Type: research

Related Links:

It has been long known that the metabolic derangements of diabetes mellitus (both type 1 and type 2) could have important effects on the central nervous system, as assessed by many cognitive measures. This has been demonstrated in adults, as well as in children.
Source: The Journal of Pediatrics - Category: Pediatrics Authors: Tags: The Editors' Perspectives Source Type: research
Publication date: Available online 22 July 2019Source: The Lancet Diabetes &EndocrinologyAuthor(s): Oana P Zaharia, Klaus Strassburger, Alexander Strom, Gidon J Bönhof, Yanislava Karusheva, Sofia Antoniou, Kálmán Bódis, Daniel F Markgraf, Volker Burkart, Karsten Müssig, Jong-Hee Hwang, Olof Asplund, Leif Groop, Emma Ahlqvist, Jochen Seissler, Peter Nawroth, Stefan Kopf, Sebastian M Schmid, Michael Stumvoll, Andreas F H PfeifferSummaryBackgroundCluster analyses have proposed different diabetes phenotypes using age, BMI, glycaemia, homoeostasis model estimates, and islet autoantibodies. We ...
Source: The Lancet Diabetes and Endocrinology - Category: Endocrinology Source Type: research
A Texas man with type 1 diabetes shares his story of overcoming hopelessness and founding a group for diabetics competing in Tough Mudder events.
Source: Diabetes Mine - Category: Endocrinology Authors: Source Type: blogs
Conditions:   Diabetes Mellitus, Type 2;   Diabetes Mellitus, Type 1 Interventions:   Drug: 3 hours humulin R 100 IU/mL PIT;   Drug: 2 hours humulin R 100 IU/mL PIT Sponsors:   Sciema UG;   Innovative Diabetes Treatment Studies LLC. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Type1diabetes Interventions:   Drug: Regular insulin (Humulin-R), intranasal route;   Device: SipNose intranasal device Sponsors:   HealthPartners Institute;   International Diabetes Center at Park Nicollet;   Juvenile Diabetes Research Foundation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Congenital malformations and perinatal mortality rates remain severalfold higher in pregnant women with type 1 diabetes than in the background population, and still only a minority of women plan their pregnancy. Optimizing glycemic control is the accepted goal, but remains challenging, and must be constantly balanced against the risks of hypoglycemia. Recent advances including Continuous Glucose Monitoring Systems, Continuous Subcutaneous Insulin Infusion, Closed Loop Devices and very Fast Acting Insulin Aspart analogs offer new possibilities to increase glucose time in target in selected, motivated patients, however their...
Source: Endocrinology and Metabolism Clinics of North America - Category: Endocrinology Authors: Source Type: research
Conclusions 147 hospitalizations due to iatrogenic hypoglycemia were identified with an estimated global cost of € 407,441. Optimizing therapy with low-risk hypoglycemic medicines, improving access to continuous glucose monitoring systems and offering adequate education, could help address the causes of hypoglycemia.
Source: International Journal of Clinical Pharmacy - Category: Drugs & Pharmacology Source Type: research
The CEO of Diasome Pharmaceuticals shares his personal type 1 diabetes story, and how their product directs insulin to the right path for best absorption.
Source: Diabetes Mine - Category: Endocrinology Authors: Source Type: blogs
To investigate in a large population the proportion of daily basal insulin dose (BD) to daily total insulin dose (TD) (BD/TD) and its association with glycated hemoglobin A1c (HbA1c),  body mass index (BMI)- SDS, and treatment modality in children with type 1 diabetes.
Source: The Journal of Pediatrics - Category: Pediatrics Authors: Tags: Original Article Source Type: research
Authors: Udler MS, McCarthy MI, Florez JC, Mahajan A Abstract Over the last decade, there have been substantial advances in the identification and characterization of DNA sequence variants associated with individual predisposition to type 1 and type 2 diabetes. As well as providing insights into the molecular, cellular and physiological mechanisms involved in disease pathogenesis, these risk variants, when combined into a polygenic score, capture information on individual patterns of disease predisposition that have the potential to influence clinical management. In this review, we describe the various opportunitie...
Source: Endocrine Reviews - Category: Endocrinology Tags: Endocr Rev Source Type: research
More News: Diabetes | Diabetes Type 1 | Endocrinology | Pediatrics | Schools